Search
Core Competency
Personal Summary
Visionary commercial executive with proven success combining scientific and business background to build innovative, customer-centric organizations that successfully launch products and deliver meaningful financial results.
Career Highlights
- 20+ years of proven results in commercial leadership (Marketing, Sales, Market Access) corporate strategy, and portfolio management
- Launch maven: 6+ brands (including product launch, label and market expansions) >$1B in annual revenue; spanning large market and rare disease and US & EX-US markets
- Team builder: Experience building teams from scratch to over 200 employees in prep for launch, reshaping to adapt to business challenges, and integrating organizations post acquisition
- Transaction experience: led $270M transaction to diversify business, adding $50M of topline revenue, pipeline asset with sales potential >$300M in peak sales, and global sales & marketing infrastructure
Past Companies
- Pfizer
- AstraZeneca
- Relypsa
Personal Summary
Results-driven C-suite executive who leverages expertise in clinical development and strategic alignment to bridge the gap between scientific discovery and the delivery of new therapies to market
Career Highlights
Broad experience partnering with boards of private companies to monitor, adapt, and react to risks while driving corporate strategy
20+ years in biopharmaceutical process development with broad modality experience in manufacturing biologics and deep understanding of potential pitfalls associated with bringing gene therapies to market
Created nimble workforce and offered operational leadership by restructuring departments, overhauling training programs, and developing cross-functional high-performing teams, that increased operational efficiency
Demonstrated success record in R&D by onboarding new technologies, while optimizing procedures to enhance productivity and reduce production costs
Allocated talent and capital to business units that created value for stakeholders
Provided strategic leadership by aggregating risks by functional area and implementing enterprise solutions that supported revenue growth
Past Companies
- Johns Hopkins University School of Medicine
- Paragon Bioservices, Inc. (acquired by Catalent)
Personal Summary
Strategy-minded business development leader and former venture capitalist with proven track record raising capital and closing complex partnerships and transactions on both the buy and sell side.
Career Highlights
“Both sides of the table” fluency as a former venture investor and seasoned operator
Significant exposure to multiple indications, modalities, and platforms as an investor with capability to understand fundamentals as a trained scientist
Extensive track-record crafting and closing complex partnerships, most recently an equity investment, collaboration, and option to acquire with Gilead Sciences
Repeat company formation and foundational partnership experience within a venture-backed drug discovery engine
Regular Board presenter on partnering, licensing, M&A and pipeline strategy
Past Companies
- Versant
- Tempest Therapeutics
- Boston Consulting Group
Personal Summary
Transformational pharma and biotech business executive and nonprofit board member with 20+ years of strategic US and global leadership.
Career Highlights
Extensive track-record of delivering double-digit growth and turning around underperforming organizations in highly competitive therapeutic areas, with organizations up to $7B
15+ product launches in US and Europe with breadth of therapeutic experience
Strengthened governance, drove organizational redesigns, and developed leadership and talent for organizations >2,000
Successfully led digital transformations/accelerated innovations through strategic partnerships (i.e, Amazon, CVS Health, Lab Corp, Mayo Clinic)
Skilled at rebuilding market confidence and engaging with investors in high-profile, crisis situations
Past Companies
Personal Summary
Accomplished C-level expert in all strategic and operational aspects of global biotherapeutic commercialization, including orphan drugs such as blood products.
Career Highlights
Led negotiation of $258 million strategic partnership and fundraising event for start-up biopharmaceutical company
Head of worldwide commercial development with P&L responsibility for >$1 billion portfolio in midsize pharmaceutical company
Successfully led corporation’s crisis management effort and initiated customer driven rationing algorithm on global basis for life and death orphan drug after manufacturing failure
Accountable for global life-cycle development strategy in hematology, immunology, respiratory and critical care therapeutic areas
Product launch implementation in US, Canada, Europe and Japan
Past Companies
- Baxter Healthcare
- Bayer Corporation
- Inspiration Biopharmaceuticals
Personal Summary
Business leader & neuroscientist. Oncology leadership and operations on several molecules & across the lifecycle. Corporate development, lifecycle leader, commercial, launch, clinical development, fundraising, deal experience.
Career Highlights
Led Corp Comm, PR, IR at public biotech: raised $10MM in 2Q22
Led Portfolio Strategy including commercial planning: forecasting, market research; Deal team-commercial & portfolio perspective for search >200 molecules, acquisition of 2 clinical assets
Lifecycle leader-multiple programs resulting in Go/No Go for indications & trial design
Accountable for launch planning in fully-integrated public company
Responsible for US commercial launch plan immunotherapy, led cross-functional team of 30+; P&L: rapid uptake, sales >$400MM Y1
Global branding, promo strategy, EU market research, int’l business team large pharma
Past Companies
- Genentech
- Campbell Alliance
Personal Summary
Accomplished biopharma leader and entrepreneur, with over 25 years of diverse industry experience leading drug-development, commercialization and business creation, coupled with experience serving on public and private biotech company boards and committees.
Career Highlights
Company building: track-record of building and leading high performing businesses from the ground-up in the US, Asia and Europe
Strategy & finance: strategic and financial/ business planning experience as CEO, BU head, country head, program/franchise head, long range & portfolio planning
P&L/commercial/drug development operations in multiple GM roles: P&L accountability for company, country affiliate, cross-functional drug development, independent global BU; operated across multiple stages of business, therapeutic areas, modalities, geographies
M&A and alliance management: business development, M&A integration, global alliance management for drug development, manufacturing, commercialization
Past Companies
- Vir Bio
- Biogen
- Harvard University
Personal Summary
Pioneering research and development executive with a strong record of delivering high-quality, differentiated candidates into the clinic and driving new scientific directions.
Career Highlights
Leader accountable for the advancement and delivery of clinical candidates across multiple modalities such as small molecules, biologics, antisense oligonucleotides, and gene therapy
Championed new scientific directions that have changed practices in the biopharmaceutical industry
Built new research groups, setting the initial strategy and identification of talent
Ability to move organizations through change at both an organizational and a team level
First-hand experience in leading collaborations with biotechnology companies. Strong understanding of the challenges and perspectives.
Past Companies
- Pfizer
Personal Summary
C-suite leader adept at building performance-driven cultures and driving business outcomesÐthrough strategy development and executionÐwithin complex, fast-growing, and highly regulated organizations.
Career Highlights
Well suited for emerging private companies or small-cap public companies Qualified to chair the Compensation Committee and serve on the Nominating & Governance Committee
Can contribute to full Board discussions involving review of strategy, CEO performance, succession planning, diversity & inclusion, M&A integration, corporate restructuring, and human capital strategy
Experience leading large-scale organizational, digital and cultural transformations, supporting global product launches and engaging medical, scientific and patient advocacy communities
Past Companies
- Biogen
- EMD Serono
- McKinsey & Company
Personal Summary
As a Top Trailblazer in Biotech, I’ve spearheaded several multi-billion dollar startups, demonstrating expertise across various leadership roles in life sciences. With a strong background in finance, sales and strategy, I leverage my background and contribute to transformative successful innovations.
Career Highlights
Launched, scaled and sold $2 billion biotech company in 3 short years
Raised over $100 billion during my career in investment banking, private equity and startups
Served in various leadership roles including CFO, CBO, CMO, and CSO across industries including pharma services, biotech, and financial services
Sourced and closed over $500 million in mergers and acquisitions, joint ventures and strategic partnerships
Recognized leader receiving awards including DEI initiative of the Year, Startup of the Year, Deal of the Year, Power Women of the Year, Top Biotech Trailblazer, Women of Influence, Young Industry All-star, Employer of the Year, Titan 100, Top Influential Philadelphian, Philly Power 100, Innovator Company of the Year, and Healthcare Power Player
Past Companies
- Deloitte
- Morgan Stanley
- EQT